Re:Cells edited using CRISPR–Cas9 injected into a person for...
by Gatsky on Tuesday November 15, 2016 @09:02PM
(#12963978)
I took the original comment to be asking why bother taking out PD-1 from the T-cells. The answer is that it obviates the need for checkpoint inhibitors, which you would otherwise need to administer together with the CAR T-cells for best efficacy. Maybe they meant something different.
Checkpoint blockade alone is a great development, but having treated patients with these drugs, I can tell you it is far from a cure for 80% of people.
It will be interesting to see if there are differences in side effect profiles in the PD-1 knockout T-cells vs our current biologicals, however.